Editorial: Recent advances in understanding the role and mechanisms of gut microbiota in inflammatory bowel disease and irritable bowel syndrome.
作者信息
Yadegar Abbas, Salahi-Niri Aryan, Dai Cong, Shen Jun
机构信息
Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China.
出版信息
Front Cell Infect Microbiol. 2024 Nov 27;14:1521676. doi: 10.3389/fcimb.2024.1521676. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Recent advances in understanding the role and mechanisms of gut microbiota in inflammatory bowel disease and irritable bowel syndrome.社论：肠道微生物群在炎症性肠病和肠易激综合征中的作用及机制研究的最新进展
Front Cell Infect Microbiol. 2024 Nov 27;14:1521676. doi: 10.3389/fcimb.2024.1521676. eCollection 2024.
2
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.新诊断、未经治疗的成人炎症性肠病和肠易激综合征患者的黏膜和粪便中的肠道微生物群。
Gut Microbes. 2022 Jan-Dec;14(1):2083419. doi: 10.1080/19490976.2022.2083419.
3
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.健康、憩室病、肠易激综合征及炎症性肠病中的肠道微生物群：是时候寻找胃肠道疾病的微生物标志物了。
Dig Dis. 2018;36(1):56-65. doi: 10.1159/000477205. Epub 2017 Jul 7.
4
The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.肠道微生物群在炎症性肠病中的作用——最新进展。
Mini Rev Med Chem. 2023;23(13):1376-1389. doi: 10.2174/1389557522666220914093331.
5
Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.前驱肠易激综合征可能是导致以未识别的克罗恩病和乳糜泻为表现的患者诊断延迟的原因，但不是溃疡性结肠炎。
Dig Dis Sci. 2011 Nov;56(11):3270-5. doi: 10.1007/s10620-011-1783-y. Epub 2011 Jun 22.
6
Gut microbiota, inflammatory bowel disease and colorectal cancer.肠道微生物群、炎症性肠病和结直肠癌。
World J Gastroenterol. 2022 Aug 14;28(30):4053-4060. doi: 10.3748/wjg.v28.i30.4053.
7
Identification of a prodromal period in Crohn's disease but not ulcerative colitis.克罗恩病前驱期的识别，但溃疡性结肠炎无此情况。
Am J Gastroenterol. 2000 Dec;95(12):3458-62. doi: 10.1111/j.1572-0241.2000.03361.x.
8
Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.缓解期炎症性肠病中肠易激综合征样症状的预测因素。
Neurogastroenterol Motil. 2024 Jun;36(6):e14809. doi: 10.1111/nmo.14809. Epub 2024 Apr 23.
9
Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.肠易激综合征和炎症性肠病的地理分布比较不能支持共同的进化根源：肠易激综合征和炎症性肠病在进化上没有关系。
Med Hypotheses. 2018 Jan;110:31-37. doi: 10.1016/j.mehy.2017.10.020. Epub 2017 Nov 2.
10
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.无菌小鼠中炎症性肠病相关肠道菌群失调的功能特征
Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul.
引用本文的文献
1
36 Mitigates Alcoholic-Associated Liver Disease Through Modulation of Microbiota and AMPK Signaling.36 通过调节微生物群和AMPK信号通路减轻酒精相关性肝病。
Nutrients. 2025 Jul 17;17(14):2340. doi: 10.3390/nu17142340.
2
Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options.炎症性肠病中的肠道微生物群失调：与肠道屏障的相互作用及针对微生物群的治疗选择
Front Cell Infect Microbiol. 2025 Jun 27;15:1608025. doi: 10.3389/fcimb.2025.1608025. eCollection 2025.
本文引用的文献
1
Lung microbiome: new insights into the pathogenesis of respiratory diseases.肺部微生物组：呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
2
The Genetics of Inflammatory Bowel Disease.炎症性肠病的遗传学。
Mol Diagn Ther. 2024 Jan;28(1):27-35. doi: 10.1007/s40291-023-00678-7. Epub 2023 Oct 17.
3
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy.炎症性肠病中的肠道微生物：药物治疗的未来新型靶向选择。
Biomed Pharmacother. 2023 Sep;165:114893. doi: 10.1016/j.biopha.2023.114893. Epub 2023 Jun 21.
4
Gut microbiota, inflammatory bowel disease and colorectal cancer.肠道微生物群、炎症性肠病和结直肠癌。
World J Gastroenterol. 2022 Aug 14;28(30):4053-4060. doi: 10.3748/wjg.v28.i30.4053.
5
Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.炎症性肠病中肠道微生物失调：当前治疗方法和调节肠道微生物治疗方法的潜力。
Bosn J Basic Med Sci. 2021 Jun 1;21(3):270-283. doi: 10.17305/bjbms.2020.5016.
6
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.
7
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer.慢性肠道炎症：炎症性肠病和结肠炎相关结肠癌。
Front Immunol. 2012 May 8;3:107. doi: 10.3389/fimmu.2012.00107. eCollection 2012.
Zotero 插件